Switzerland: Management News Roche Announces Changes to Company Management

Editor: MA Alexander Stark

Roche announced that at its December meeting the Board of Directors has approved first proposals to the planned changes in the Board of Directors and the Corporate Executive Committee.

Related Vendors

Dr Jörg Duschmalé is to succeed Dr Andreas Oeri in the Board of Directors.
Dr Jörg Duschmalé is to succeed Dr Andreas Oeri in the Board of Directors.
(Source: Roche)

Basel/Switzerland — As already announced in July 2018, Dr Andreas Oeri (70) will retire from Roche's Board of Directors after 25 years in office with the Annual General Meeting in 2020. Dr Jörg Duschmalé (35), representing the fifth generation of the company's founder's descendants, will stand for election as his successor.

After 18 years of service on the Board, Professor Sir John Bell has also decided not to stand for re-election to the Board of Directors at the 2020 Annual General Meeting. The Board of Directors will propose Dr Patrick Frost (51), CEO of the Swiss Life Group, for election at the Annual General Meeting in 2020.

Dr Gottlieb A. Keller (65), General Counsel, member of the Corporate Executive Committee, and Secretary to the Board of Directors, will retire at the end of March 2020. The Board of Directors has appointed Claudia Böckstiegel (55), currently Head of Legal of the Diagnostics Division, to the position of General Counsel, and she will become a member of the Enlarged Corporate Executive Committee as of 1 April 2020.

Dr Annette Luther (49), currently General Manager of Roche Diagnostics International in Rotkreuz, will succeed Dr Gottlieb Keller as Secretary to the Board of Directors.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent